市场快照
| Study Period: | 2018 - 2026 |
| Base Year: | 2021 |
| CAGR: | 5.2 % |
|
Need a report that reflects how COVID-19 has impacted this market and its growth?
市场概况
癌症和心脏病发病率的上升是市场增长的主要驱动力之一。核医学在治疗癌症和心脏病方面具有巨大的能力。由于人口老龄化、饮食不良、吸烟和缺乏运动等因素，癌症负担正在增加。据阿布扎比卫生部称，2018 年，阿拉伯联合酋长国 (UAE) 每年新增约 4,500 例癌症病例。根据世界卫生组织 (WHO) 的数据，中东地区的癌症发病率正在上升，预计到 2030 年病例数将翻一番。心脏病学应用可能会继续在市场上表现出显着增长。在心脏病学领域，核医学成像在冠状动脉疾病 (CAD) 患者的诊断和管理中发挥着至关重要的作用，动脉粥样硬化和其他心血管疾病。核医学在多种疾病患者的诊断和管理中发挥着重要作用，这是所研究市场的关键增长因素。
Scope of the report
As per the scope of the report, Nuclear medicine imaging procedures are non-invasive, with the exception of intravenous injections, and are usually painless medical tests that help physicians diagnose and evaluate medical conditions. These imaging scans use radioactive materials called radiopharmaceuticals or radiotracers. These radiopharmaceuticals are used in diagnosis and therapeutics. These are small substances that contain a radioactive substance that is used in the treatment of cancer, cardiac and neurological disorders.
| By Product | ||||||||||||||||
| By Equipment | ||||||||||||||||
|
| By Application | ||||||
| ||||||
|
| Geography | |||||
|
主要市场趋势
Technetium-99m 细分市场预计将在预测年份显示出更好的增长
基于 SPECT 放射性同位素，市场分为锝 99m、铊 201、镓 67、碘 123 等。锝 99m 被认为是多种诊断程序中使用最广泛的同位素。它用于 SPECT 成像、心室造影、脑成像、骨扫描和 3D 扫描技术。
To understand key trends, Download Sample Report
竞争格局
进入中东核成像市场的全球参与者包括 Bracco Imaging SpA、Cardinal Health Inc.、Curium、GE Healthcare、Koninklijke Philips NV、NTP Radioisotopes SOC Ltd、Siemens AG 和东芝公司。
Table of Contents
-
1. INTRODUCTION
-
1.1 Study Deliverables
-
1.2 Study Assumptions
-
1.3 Scope of the Study
-
-
2. RESEARCH METHODOLOGY
-
3. EXECUTIVE SUMMARY
-
4. MARKET DYNAMICS
-
4.1 Market Overview
-
4.2 Market Drivers
-
4.2.1 Rise in Prevalence of Cancer and Cardiac Disorders
-
4.2.2 Growth in Applications of Nuclear Medicine and Imaging
-
-
4.3 Market Restraints
-
4.3.1 Stringent RegulatIons
-
4.3.2 Reimbursement Issues
-
-
4.4 Porter's Five Forces Analysis
-
4.4.1 Threat of New Entrants
-
4.4.2 Bargaining Power of Buyers/Consumers
-
4.4.3 Bargaining Power of Suppliers
-
4.4.4 Threat of Substitute Products
-
4.4.5 Intensity of Competitive Rivalry
-
-
-
5. MARKET SEGMENTATION
-
5.1 By Product
-
5.1.1 By Equipment
-
5.1.2 By Radioisotope
-
5.1.2.1 By Diagnostic Technology
-
5.1.2.1.1 SPECT Radioisotopes
-
5.1.2.1.1.1 Technetium-99m (TC-99m)
-
5.1.2.1.1.2 Thallium-201 (TI-201)
-
5.1.2.1.1.3 Gallium-67 (Ga-67)
-
5.1.2.1.1.4 Iodine-123 (I-123)
-
5.1.2.1.1.5 Other SPECT Radioisotopes
-
-
5.1.2.1.2 PET Radioisotopes
-
5.1.2.1.2.1 Fluorine-18 (F-18)
-
5.1.2.1.2.2 Rubidium-82 (RB-82)
-
5.1.2.1.2.3 Other PET Radioisotopes
-
-
-
-
-
5.2 By Application
-
5.2.1 SPECT Applications
-
5.2.1.1 Cardiology
-
5.2.1.2 Neurology
-
5.2.1.3 Thyroid
-
5.2.1.4 Other SPECT Applications
-
-
5.2.2 PET Applications
-
5.2.2.1 Cardiology
-
5.2.2.2 Neurology
-
5.2.2.3 Oncology
-
5.2.2.4 Other PET Applications
-
-
-
5.3 Geography
-
5.3.1 Middle-East and Africa
-
5.3.1.1 GCC
-
5.3.1.2 South Africa
-
5.3.1.3 Rest of Middle-East and Africa
-
-
-
-
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
-
6.1.1 Bracco Imaging SpA
-
6.1.2 Cardinal Health Inc.
-
6.1.3 Curium
-
6.1.4 GE Healthcare
-
6.1.5 Koninklijke Philips N.V
-
6.1.6 NTP Radioisotopes SOC Ltd
-
6.1.7 Siemens AG
-
6.1.8 Toshiba Corporation
-
*List Not Exhaustive -
-
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
You can also purchase parts of this report. Do you want to check out a section wise price list?
Frequently Asked Questions
What is the study period of this market?
The Middle East Nuclear Imaging Market market is studied from 2018 - 2026.
What is the growth rate of Middle East Nuclear Imaging Market?
The Middle East Nuclear Imaging Market is growing at a CAGR of 5.2% over the next 5 years.
Who are the key players in Middle East Nuclear Imaging Market?
Bracco Imaging SpA, Cardinal Health Inc., GE Healthcare, Koninklijke Philips N.V, Siemens AG are the major companies operating in Middle East Nuclear Imaging Market.
